Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
Background: Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based clinical guidelines for the management of...
Gespeichert in:
| Veröffentlicht in: | Thyroid (New York, N.Y.) N.Y.), 2011-06, Vol.21 (6), p.593-646 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 646 |
|---|---|
| container_issue | 6 |
| container_start_page | 593 |
| container_title | Thyroid (New York, N.Y.) |
| container_volume | 21 |
| creator | Bahn, Rebecca S. Burch, Henry B. Cooper, David S. Garber, Jeffrey R. Greenlee, M. Carol Klein, Irwin Laurberg, Peter McDougall, I. Ross Montori, Victor M. Rivkees, Scott A. Ross, Douglas S. Sosa, Julie Ann Stan, Marius N. |
| description | Background:
Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition.
Methods:
The development of these guidelines was commissioned by the American Thyroid Association in association with the American Association of Clinical Endocrinologists. The American Thyroid Association and American Association of Clinical Endocrinologists assembled a task force of expert clinicians who authored this report. The task force examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to develop the text and a series of specific recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group.
Results:
Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves' disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves' ophthalmopathy; and management of other miscellaneous causes of thyrotoxicosis.
Conclusions:
One hundred evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice. |
| doi_str_mv | 10.1089/thy.2010.0417 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A259590068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A259590068</galeid><sourcerecordid>A259590068</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-6063aafaf614d0a6e45b6500a8eb0509ac05e098e8d2c35441ce02cec7a717263</originalsourceid><addsrcrecordid>eNqFkU9r3DAQxUVoaP60x1yLoGdvR7Yl2b0tS5oUEnJJz2ZWGm9UbGmRvND9PPmilesmtFAoOkia-b13eI-xKwErAU37aXo6rkrIP6iFPmHnQkpdtKD1m_wGCYUupTpjFyl9BxCq0dVbdlYKmcUgztnz7XFPMZvE4KxLI0dv-cP0RJFv8JAo8dDzx3k9hR_OhOTSZ36PHnc0kp_4zcFZGpxfwKzj65GiM-gXlbN8nVIwDicX_C_3V-DPRRZvsk2eD_za22Ci82EIO5em9I6d9jgkev_7vmTfvlw_bm6Lu4ebr5v1XWFq1U6FAlUh9tgrUVtARbXcKgmADW1zEC0akARtQ40tTSXrWhiC0pDRqIUuVXXJPi6-Oxyoc74PU0QzumS6dSlb2QKoJlOrf1D5WBpzQJ56l-d_CYpFYGJIKVLf7aMbMR47Ad3cYZfj7-YOu7nDzH9Y-P1hO5J9pV9Ky0C1APMYvR8cbXOH_7H9CWGnq4k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bahn, Rebecca S. ; Burch, Henry B. ; Cooper, David S. ; Garber, Jeffrey R. ; Greenlee, M. Carol ; Klein, Irwin ; Laurberg, Peter ; McDougall, I. Ross ; Montori, Victor M. ; Rivkees, Scott A. ; Ross, Douglas S. ; Sosa, Julie Ann ; Stan, Marius N.</creator><creatorcontrib>Bahn, Rebecca S. ; Burch, Henry B. ; Cooper, David S. ; Garber, Jeffrey R. ; Greenlee, M. Carol ; Klein, Irwin ; Laurberg, Peter ; McDougall, I. Ross ; Montori, Victor M. ; Rivkees, Scott A. ; Ross, Douglas S. ; Sosa, Julie Ann ; Stan, Marius N. ; American Thyroid Association ; American Association of Clinical Endocrinologists ; The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis</creatorcontrib><description>Background:
Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition.
Methods:
The development of these guidelines was commissioned by the American Thyroid Association in association with the American Association of Clinical Endocrinologists. The American Thyroid Association and American Association of Clinical Endocrinologists assembled a task force of expert clinicians who authored this report. The task force examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to develop the text and a series of specific recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group.
Results:
Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves' disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves' ophthalmopathy; and management of other miscellaneous causes of thyrotoxicosis.
Conclusions:
One hundred evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice.</description><identifier>ISSN: 1050-7256</identifier><identifier>EISSN: 1557-9077</identifier><identifier>DOI: 10.1089/thy.2010.0417</identifier><identifier>PMID: 21510801</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Adolescent ; Adrenergic beta-Antagonists - therapeutic use ; Antithyroid Agents - therapeutic use ; Care and treatment ; Child ; Evidence-Based Medicine ; Female ; Graves Disease - therapy ; Humans ; Hyperthyroidism ; Hyperthyroidism - therapy ; Hyperthyroidism, Other Causes of Thyrotoxicosis, and Thyroid Hormone Action ; Iodine Radioisotopes - therapeutic use ; Original Studies, Reviews, and Scholarly Dialog ; Practice guidelines (Medicine) ; Pregnancy ; Thyroid Crisis - therapy ; Thyroid Hormones - therapeutic use ; Thyroidectomy ; Thyrotoxicosis - diagnosis ; Thyrotoxicosis - therapy</subject><ispartof>Thyroid (New York, N.Y.), 2011-06, Vol.21 (6), p.593-646</ispartof><rights>2011, Mary Ann Liebert, Inc.</rights><rights>COPYRIGHT 2011 Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-6063aafaf614d0a6e45b6500a8eb0509ac05e098e8d2c35441ce02cec7a717263</citedby><cites>FETCH-LOGICAL-c469t-6063aafaf614d0a6e45b6500a8eb0509ac05e098e8d2c35441ce02cec7a717263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21510801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bahn, Rebecca S.</creatorcontrib><creatorcontrib>Burch, Henry B.</creatorcontrib><creatorcontrib>Cooper, David S.</creatorcontrib><creatorcontrib>Garber, Jeffrey R.</creatorcontrib><creatorcontrib>Greenlee, M. Carol</creatorcontrib><creatorcontrib>Klein, Irwin</creatorcontrib><creatorcontrib>Laurberg, Peter</creatorcontrib><creatorcontrib>McDougall, I. Ross</creatorcontrib><creatorcontrib>Montori, Victor M.</creatorcontrib><creatorcontrib>Rivkees, Scott A.</creatorcontrib><creatorcontrib>Ross, Douglas S.</creatorcontrib><creatorcontrib>Sosa, Julie Ann</creatorcontrib><creatorcontrib>Stan, Marius N.</creatorcontrib><creatorcontrib>American Thyroid Association</creatorcontrib><creatorcontrib>American Association of Clinical Endocrinologists</creatorcontrib><creatorcontrib>The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis</creatorcontrib><title>Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists</title><title>Thyroid (New York, N.Y.)</title><addtitle>Thyroid</addtitle><description>Background:
Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition.
Methods:
The development of these guidelines was commissioned by the American Thyroid Association in association with the American Association of Clinical Endocrinologists. The American Thyroid Association and American Association of Clinical Endocrinologists assembled a task force of expert clinicians who authored this report. The task force examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to develop the text and a series of specific recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group.
Results:
Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves' disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves' ophthalmopathy; and management of other miscellaneous causes of thyrotoxicosis.
Conclusions:
One hundred evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice.</description><subject>Adolescent</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Antithyroid Agents - therapeutic use</subject><subject>Care and treatment</subject><subject>Child</subject><subject>Evidence-Based Medicine</subject><subject>Female</subject><subject>Graves Disease - therapy</subject><subject>Humans</subject><subject>Hyperthyroidism</subject><subject>Hyperthyroidism - therapy</subject><subject>Hyperthyroidism, Other Causes of Thyrotoxicosis, and Thyroid Hormone Action</subject><subject>Iodine Radioisotopes - therapeutic use</subject><subject>Original Studies, Reviews, and Scholarly Dialog</subject><subject>Practice guidelines (Medicine)</subject><subject>Pregnancy</subject><subject>Thyroid Crisis - therapy</subject><subject>Thyroid Hormones - therapeutic use</subject><subject>Thyroidectomy</subject><subject>Thyrotoxicosis - diagnosis</subject><subject>Thyrotoxicosis - therapy</subject><issn>1050-7256</issn><issn>1557-9077</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9r3DAQxUVoaP60x1yLoGdvR7Yl2b0tS5oUEnJJz2ZWGm9UbGmRvND9PPmilesmtFAoOkia-b13eI-xKwErAU37aXo6rkrIP6iFPmHnQkpdtKD1m_wGCYUupTpjFyl9BxCq0dVbdlYKmcUgztnz7XFPMZvE4KxLI0dv-cP0RJFv8JAo8dDzx3k9hR_OhOTSZ36PHnc0kp_4zcFZGpxfwKzj65GiM-gXlbN8nVIwDicX_C_3V-DPRRZvsk2eD_za22Ci82EIO5em9I6d9jgkev_7vmTfvlw_bm6Lu4ebr5v1XWFq1U6FAlUh9tgrUVtARbXcKgmADW1zEC0akARtQ40tTSXrWhiC0pDRqIUuVXXJPi6-Oxyoc74PU0QzumS6dSlb2QKoJlOrf1D5WBpzQJ56l-d_CYpFYGJIKVLf7aMbMR47Ad3cYZfj7-YOu7nDzH9Y-P1hO5J9pV9Ky0C1APMYvR8cbXOH_7H9CWGnq4k</recordid><startdate>20110601</startdate><enddate>20110601</enddate><creator>Bahn, Rebecca S.</creator><creator>Burch, Henry B.</creator><creator>Cooper, David S.</creator><creator>Garber, Jeffrey R.</creator><creator>Greenlee, M. Carol</creator><creator>Klein, Irwin</creator><creator>Laurberg, Peter</creator><creator>McDougall, I. Ross</creator><creator>Montori, Victor M.</creator><creator>Rivkees, Scott A.</creator><creator>Ross, Douglas S.</creator><creator>Sosa, Julie Ann</creator><creator>Stan, Marius N.</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20110601</creationdate><title>Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists</title><author>Bahn, Rebecca S. ; Burch, Henry B. ; Cooper, David S. ; Garber, Jeffrey R. ; Greenlee, M. Carol ; Klein, Irwin ; Laurberg, Peter ; McDougall, I. Ross ; Montori, Victor M. ; Rivkees, Scott A. ; Ross, Douglas S. ; Sosa, Julie Ann ; Stan, Marius N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-6063aafaf614d0a6e45b6500a8eb0509ac05e098e8d2c35441ce02cec7a717263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Antithyroid Agents - therapeutic use</topic><topic>Care and treatment</topic><topic>Child</topic><topic>Evidence-Based Medicine</topic><topic>Female</topic><topic>Graves Disease - therapy</topic><topic>Humans</topic><topic>Hyperthyroidism</topic><topic>Hyperthyroidism - therapy</topic><topic>Hyperthyroidism, Other Causes of Thyrotoxicosis, and Thyroid Hormone Action</topic><topic>Iodine Radioisotopes - therapeutic use</topic><topic>Original Studies, Reviews, and Scholarly Dialog</topic><topic>Practice guidelines (Medicine)</topic><topic>Pregnancy</topic><topic>Thyroid Crisis - therapy</topic><topic>Thyroid Hormones - therapeutic use</topic><topic>Thyroidectomy</topic><topic>Thyrotoxicosis - diagnosis</topic><topic>Thyrotoxicosis - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bahn, Rebecca S.</creatorcontrib><creatorcontrib>Burch, Henry B.</creatorcontrib><creatorcontrib>Cooper, David S.</creatorcontrib><creatorcontrib>Garber, Jeffrey R.</creatorcontrib><creatorcontrib>Greenlee, M. Carol</creatorcontrib><creatorcontrib>Klein, Irwin</creatorcontrib><creatorcontrib>Laurberg, Peter</creatorcontrib><creatorcontrib>McDougall, I. Ross</creatorcontrib><creatorcontrib>Montori, Victor M.</creatorcontrib><creatorcontrib>Rivkees, Scott A.</creatorcontrib><creatorcontrib>Ross, Douglas S.</creatorcontrib><creatorcontrib>Sosa, Julie Ann</creatorcontrib><creatorcontrib>Stan, Marius N.</creatorcontrib><creatorcontrib>American Thyroid Association</creatorcontrib><creatorcontrib>American Association of Clinical Endocrinologists</creatorcontrib><creatorcontrib>The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Thyroid (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bahn, Rebecca S.</au><au>Burch, Henry B.</au><au>Cooper, David S.</au><au>Garber, Jeffrey R.</au><au>Greenlee, M. Carol</au><au>Klein, Irwin</au><au>Laurberg, Peter</au><au>McDougall, I. Ross</au><au>Montori, Victor M.</au><au>Rivkees, Scott A.</au><au>Ross, Douglas S.</au><au>Sosa, Julie Ann</au><au>Stan, Marius N.</au><aucorp>American Thyroid Association</aucorp><aucorp>American Association of Clinical Endocrinologists</aucorp><aucorp>The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists</atitle><jtitle>Thyroid (New York, N.Y.)</jtitle><addtitle>Thyroid</addtitle><date>2011-06-01</date><risdate>2011</risdate><volume>21</volume><issue>6</issue><spage>593</spage><epage>646</epage><pages>593-646</pages><issn>1050-7256</issn><eissn>1557-9077</eissn><abstract>Background:
Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition.
Methods:
The development of these guidelines was commissioned by the American Thyroid Association in association with the American Association of Clinical Endocrinologists. The American Thyroid Association and American Association of Clinical Endocrinologists assembled a task force of expert clinicians who authored this report. The task force examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to develop the text and a series of specific recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group.
Results:
Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves' disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves' ophthalmopathy; and management of other miscellaneous causes of thyrotoxicosis.
Conclusions:
One hundred evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>21510801</pmid><doi>10.1089/thy.2010.0417</doi><tpages>54</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1050-7256 |
| ispartof | Thyroid (New York, N.Y.), 2011-06, Vol.21 (6), p.593-646 |
| issn | 1050-7256 1557-9077 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A259590068 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adolescent Adrenergic beta-Antagonists - therapeutic use Antithyroid Agents - therapeutic use Care and treatment Child Evidence-Based Medicine Female Graves Disease - therapy Humans Hyperthyroidism Hyperthyroidism - therapy Hyperthyroidism, Other Causes of Thyrotoxicosis, and Thyroid Hormone Action Iodine Radioisotopes - therapeutic use Original Studies, Reviews, and Scholarly Dialog Practice guidelines (Medicine) Pregnancy Thyroid Crisis - therapy Thyroid Hormones - therapeutic use Thyroidectomy Thyrotoxicosis - diagnosis Thyrotoxicosis - therapy |
| title | Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A35%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperthyroidism%20and%20Other%20Causes%20of%20Thyrotoxicosis:%20Management%20Guidelines%20of%20the%20American%20Thyroid%20Association%20and%20American%20Association%20of%20Clinical%20Endocrinologists&rft.jtitle=Thyroid%20(New%20York,%20N.Y.)&rft.au=Bahn,%20Rebecca%20S.&rft.aucorp=American%20Thyroid%20Association&rft.date=2011-06-01&rft.volume=21&rft.issue=6&rft.spage=593&rft.epage=646&rft.pages=593-646&rft.issn=1050-7256&rft.eissn=1557-9077&rft_id=info:doi/10.1089/thy.2010.0417&rft_dat=%3Cgale_cross%3EA259590068%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21510801&rft_galeid=A259590068&rfr_iscdi=true |